Jeff Yass: Tenet Healthcare THC Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 50.4 M | Venta |
197,100
-46,300
| -19% | -USD 11.4 M | ﹤0.01% | 1456 |
|
|
2026
Q2 | USD 45.5 M | Compra |
243,400
+164,100
| +207% | +USD 30.2 M | ﹤0.01% | 1603 |
|
|
2026
Q1 | USD 15 M | Venta |
79,300
-78,700
| -50% | -USD 16.6 M | ﹤0.01% | 2566 |
|
|
2025
Q4 | USD 31.4 M | Venta |
158,000
-112,600
| -42% | -USD 22.8 M | ﹤0.01% | 1777 |
|
|
2025
Q3 | USD 54.9 M | Compra |
270,600
+4,200
| +2% | +USD 745 k | 0.01% | 1276 |
|
|
2025
Q2 | USD 46.9 M | Compra |
266,400
+44,200
| +20% | +USD 6.65 M | 0.01% | 1218 |
|
|
2025
Q1 | USD 29.9 M | Venta |
222,200
-104,700
| -32% | -USD 13.8 M | 0.01% | 1394 |
|
|
2024
Q4 | USD 41.3 M | Venta |
326,900
-130,500
| -29% | -USD 19.4 M | 0.01% | 1262 |
|
|
2024
Q3 | USD 76 M | Venta |
457,400
-68,000
| -13% | -USD 10.3 M | 0.01% | 818 |
|
|
2024
Q2 | USD 69.9 M | Compra |
525,400
+69,600
| +15% | +USD 8.38 M | 0.01% | 780 |
|
|
2024
Q1 | USD 47.9 M | Compra |
455,800
+166,500
| +58% | +USD 15 M | 0.01% | 1065 |
|
|
2023
Q4 | USD 21.9 M | Compra |
289,300
+91,400
| +46% | +USD 5.79 M | ﹤0.01% | 1714 |
|
|
2023
Q3 | USD 13 M | Venta |
197,900
-159,000
| -45% | -USD 11.9 M | ﹤0.01% | 2226 |
|
|
2023
Q2 | USD 29 M | Compra |
356,900
+171,800
| +93% | +USD 12.2 M | 0.01% | 1388 |
|
|
2023
Q1 | USD 11 M | Venta |
185,100
-268,500
| -59% | -USD 14.9 M | ﹤0.01% | 2325 |
|
|
2022
Q4 | USD 22.1 M | Compra |
453,600
+263,200
| +138% | +USD 12.2 M | 0.01% | 1431 |
|
|
2022
Q3 | USD 9.8 M | Venta |
190,400
-16,200
| -8% | -USD 961 k | ﹤0.01% | 2178 |
|
|
2022
Q2 | USD 10.9 M | Venta |
206,600
-106,900
| -34% | -USD 7.44 M | ﹤0.01% | 2100 |
|
|
2022
Q1 | USD 26.9 M | Venta |
313,500
-2,100
| -0.7% | -USD 173 k | ﹤0.01% | 1427 |
|
|
2021
Q4 | USD 25.8 M | Compra |
315,600
+39,300
| +14% | +USD 2.87 M | ﹤0.01% | 1600 |
|
|
2021
Q3 | USD 18.4 M | Compra |
276,300
+28,500
| +12% | +USD 2.02 M | ﹤0.01% | 2066 |
|
|
2021
Q2 | USD 16.6 M | Compra |
247,800
+118,200
| +91% | +USD 7.33 M | ﹤0.01% | 2267 |
|
|
2021
Q1 | USD 6.74 M | Venta |
129,600
-436,100
| -77% | -USD 22 M | ﹤0.01% | 3396 |
|
|
2020
Q4 | USD 22.6 M | Venta |
565,700
-178,100
| -24% | -USD 5.75 M | ﹤0.01% | 1605 |
|
|
2020
Q3 | USD 18.2 M | Venta |
743,800
-345,500
| -32% | -USD 8.83 M | ﹤0.01% | 1563 |
|
|
2020
Q2 | USD 19.7 M | Compra |
1,089,300
+542,700
| +99% | +USD 10.7 M | ﹤0.01% | 1439 |
|
|
2020
Q1 | USD 7.87 M | Compra |
546,600
+800
| +0.1% | +USD 23 k | ﹤0.01% | 2032 |
|
|
2019
Q4 | USD 20.8 M | Venta |
545,800
-31,800
| -6% | -USD 952 k | 0.01% | 1381 |
|
|
2019
Q3 | USD 12.8 M | Venta |
577,600
-18,700
| -3% | -USD 398 k | ﹤0.01% | 1727 |
|
|
2019
Q2 | USD 12.3 M | Compra |
596,300
+107,800
| +22% | +USD 2.48 M | ﹤0.01% | 1690 |
|
|
2019
Q1 | USD 14.1 M | Compra |
488,500
+237,400
| +95% | +USD 5.86 M | 0.01% | 1460 |
|
|
2018
Q4 | USD 4.3 M | Venta |
251,100
-79,000
| -24% | -USD 1.91 M | ﹤0.01% | 2460 |
|
|
2018
Q3 | USD 9.4 M | Venta |
330,100
-659,800
| -67% | -USD 21.8 M | ﹤0.01% | 2002 |
|
|
2018
Q2 | USD 33.2 M | Compra |
989,900
+218,200
| +28% | +USD 6.78 M | 0.01% | 924 |
|
|
2018
Q1 | USD 18.7 M | Venta |
771,700
-3,630,200
| -82% | -USD 72.3 M | 0.01% | 1271 |
|
|
2017
Q4 | USD 66.7 M | Compra |
4,401,900
+34,200
| +0.8% | +USD 481 k | 0.02% | 574 |
|
|
2017
Q3 | USD 71.8 M | Compra |
4,367,700
+3,613,600
| +479% | +USD 61.3 M | 0.03% | 503 |
|
|
2017
Q2 | USD 14.6 M | Venta |
754,100
-165,500
| -18% | -USD 2.89 M | 0.01% | 1392 |
|
|
2017
Q1 | USD 16.3 M | Compra |
919,600
+256,200
| +39% | +USD 4.75 M | 0.01% | 1230 |
|
|
2016
Q4 | USD 9.8 M | Compra |
663,400
+94,400
| +17% | +USD 1.69 M | 0.01% | 1578 |
|
|
2016
Q3 | USD 12.9 M | Venta |
569,000
-139,700
| -20% | -USD 3.64 M | 0.01% | 1332 |
|
|
2016
Q2 | USD 19.6 M | Compra |
708,700
+402,100
| +131% | +USD 11.9 M | 0.01% | 993 |
|
|
2016
Q1 | USD 8.87 M | Venta |
306,600
-495,100
| -62% | -USD 12.9 M | ﹤0.01% | 1674 |
|
|
2015
Q4 | USD 24.3 M | Compra |
801,700
+303,300
| +61% | +USD 9.9 M | 0.01% | 1007 |
|
|
2015
Q3 | USD 18.4 M | Venta |
498,400
-1,280,900
| -72% | -USD 66.2 M | 0.01% | 1283 |
|
|
2015
Q2 | USD 103 M | Compra |
1,779,300
+920,500
| +107% | +USD 47 M | 0.04% | 389 |
|
|
2015
Q1 | USD 42.5 M | Compra |
858,800
+131,800
| +18% | +USD 6.16 M | 0.02% | 714 |
|
|
2014
Q4 | USD 36.8 M | Compra |
727,000
+466,000
| +179% | +USD 24.4 M | 0.01% | 909 |
|
|
2014
Q3 | USD 15.5 M | Venta |
261,000
-637,700
| -71% | -USD 35.6 M | 0.01% | 1663 |
|
|
2014
Q2 | USD 42.2 M | Compra |
898,700
+525,300
| +141% | +USD 23.7 M | 0.02% | 820 |
|
|
2014
Q1 | USD 16 M | Compra |
373,400
+156,400
| +72% | +USD 6.9 M | 0.01% | 1493 |
|
|
2013
Q4 | USD 9.14 M | Venta |
217,000
-42,600
| -16% | -USD 1.85 M | ﹤0.01% | 2169 |
|
|
2013
Q3 | USD 10.7 M | Compra |
259,600
+170,400
| +191% | +USD 7.13 M | 0.01% | 1827 |
|
|
2013
Q2 | USD 4.11 M | Compra |
+89,200
| Nuevas | +USD 3.99 M | ﹤0.01% | 2874 |
|
Otros fondos que tienen THC en su portafolio
Posición de Jeff Yass en THC: resumen de T3 2026
Jeff Yass aumentó su participación en Tenet Healthcare (THC) en 618% durante T3 2026, al comprar aproximadamente USD 22.1 M y elevar la posición a 104,260 acciones con un valor de USD 26.6 M. La posición representa ﹤0.01% del portafolio y ocupa el puesto #2087.
Jeff Yass reportó por primera vez una posición en THC en T2 2013 y desde entonces la ha mantenido en 48 trimestres. La posición alcanzó su máximo de USD 30 M en T2 2015. Al cierre de T3 2026, 784 fondos que sigue Wall St. Rank mantienen una posición en THC.
- Al cierre de T3 2026, Jeff Yass tenía 104,260 acciones de Tenet Healthcare con un valor de USD 26.6 M.
- Jeff Yass compró 89,730 acciones de Tenet Healthcare en T3 2026, por un monto estimado de USD 22.1 M.
- Tenet Healthcare representó el ﹤0.01% del portafolio de Jeff Yass en T3 2026 y fue su posición número 2087.
- Jeff Yass reportó por primera vez una posición en Tenet Healthcare en T2 2013 y desde entonces la ha mantenido en 48 trimestres.
- La posición de Jeff Yass en Tenet Healthcare alcanzó su máximo de USD 30 M en T2 2015.
- Al cierre de T3 2026, 784 fondos que sigue Wall St. Rank tenían Tenet Healthcare en su portafolio.
Según el informe 13F de Susquehanna International Group correspondiente a T3 2026, presentado el 16 nov 2026.